Diabetes-related complications often bring to mind kidney disease, neuropathy, or vision problems. However, one complication continues to receive far less attention despite growing scientific concern: hearing loss linked to diabetes. Emerging evidence suggests that people with diabetes may face a significantly higher risk of hearing decline, yet routine auditory screening …
Read More »The Rise of “Double Diabetes”: Why More Adults With Type 1 Diabetes Are Developing Insulin Resistance
More adults living with type 1 diabetes are now developing obesity, insulin resistance, hypertension, and metabolic complications once linked mainly to type 2 diabetes. This growing overlap, often called double diabetes, is becoming a major concern for clinicians and patients alike. While insulin therapy remains essential for type 1 diabetes …
Read More »Open-Source Diabetes Technology Is Entering the Mainstream: Are Clinicians Ready?
The conversation around DIY diabetes technology and patient-led insulin automation has changed dramatically over the past few years. What once existed on the margins of diabetes care is now gaining recognition from major medical organizations and healthcare providers. In fact, the 2026 American Diabetes Association (ADA) Standards of Care continue …
Read More »Is Carb Counting Becoming Obsolete? The Rise of Precision Nutrition in Diabetes Care
A bowl of oatmeal can keep one person’s glucose stable while sending another person’s blood sugar sharply upward. The meal is identical, yet the metabolic response is completely different. That reality is pushing many clinicians to reconsider one of the most established principles in diabetes nutrition: carb counting. The growing …
Read More »Diabetes Burnout Is Rising in the Age of Always-On Technology
A glucose alarm goes off during dinner. Another alert appears at 2 a.m. A smartphone app flashes warnings about rising blood sugar before the day even starts. Diabetes technology promises better control, yet for some patients, the nonstop stream of notifications and health data can feel mentally exhausting. Clinicians are …
Read More »Beyond the FIB-4: Why Diabetes Care Is Becoming a Hepatology-Endocrinology Partnership
Screening for fatty liver disease in patients with diabetes is no longer limited to identifying elevated liver enzymes or calculating a fibrosis score during an annual visit. Instead, clinicians are entering an era where diabetes care and hepatology increasingly overlap, especially as metabolic dysfunction-associated steatotic liver disease, or MASLD, becomes …
Read More »The FDA’s New Insulin Switching Rules: What Interchangeable Biosimilars Mean for Diabetes Care
A patient arrives at the pharmacy expecting their usual insulin refill, only to discover the box, brand name, and pen device suddenly look different. The pharmacist explains that the medication is an interchangeable biosimilar approved for automatic substitution. Although the insulin is considered clinically equivalent, the unexpected switch can still …
Read More »Treatment Complexity in Type 2 Diabetes: When More Options Make Decisions Harder
Managing Type 2 diabetes used to follow a relatively predictable path. Clinicians often started with metformin and added medications gradually as glucose control worsened. Today, however, diabetes care looks very different. The number of available therapies has expanded rapidly, and while that growth has improved patient outcomes, it has also …
Read More »The Diabetes Diagnosis Gap: Are We Missing Patients Who Don’t Fit Classic Risk Profiles?
Diabetes screening has improved over the last two decades, yet many patients still fall through the cracks. While clinicians often rely on traditional risk models that focus on obesity, age, family history, and sedentary lifestyle, not every patient with diabetes fits that familiar picture. As a result, many diabetes cases …
Read More »When GLP-1 Therapy Plateaus: What Clinicians Should Do Next
Everything seems to be working perfectly until it suddenly isn’t. A patient is losing weight steadily, HbA1c levels are improving, and confidence is high during every follow-up visit. Then progress slows. The scale barely changes. Blood sugar readings stop improving. Patients start asking whether the medication has stopped working, while …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.